Madrigal Pharmaceuticals Inc
NASDAQ. Currency in USD
234.83 +171.03 ( +268.07% )
Beta (5Y monthly)
1y Target Est.
52 Week's Range
About Madrigal Pharmaceuticals Inc
Four Tower Bridge, West Conshohocken, PA, United States, 19428
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced...
By Benzinga - 6 weeks ago
The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug.
By The Motley Fool - 6 weeks ago
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th
CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage...
By GlobeNewswire Inc. - 7 weeks ago
These two healthcare stocks could deliver market-crushing gains by year's end.
By The Motley Fool - 13 weeks ago
NASH is a common disease, but there are no approved treatments for it. These two...
By The Motley Fool - 20 weeks ago